Drugs for Spastic Paraplegia 7, Autosomal Recessive (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):
(show all 31)
# |
|
Name |
Status |
Phase |
Clinical Trials |
Cas Number |
PubChem Id |
1 |
|
Acetylcholine |
Approved, Investigational |
Phase 2, Phase 3 |
|
51-84-3 |
187 |
Synonyms:
2-(Acetyloxy)-N,N,N-trimethylethanaminium
Acetilcolina cusi
Acetyl choline ion
Acetylcholine bromide
Acetylcholine cation
acetylcholine chloride
Acetylcholine chloride
Acetylcholine fluoride
Acetylcholine hydroxide
Acetylcholine iodide
Acetylcholine L tartrate
Acetylcholine L-tartrate
Acetylcholine perchlorate
Acetylcholine picrate
Acetylcholine picrate (1:1)
Acetylcholine sulfate (1:1)
Acetylcholinium: acetyl-choline
ACh
Alcon brand OF acetylcholine chloride
|
Azetylcholin
Bournonville brand OF acetylcholine chloride
Bromide, acetylcholine
Bromoacetylcholine
Chloroacetylcholine
Choline acetate
Choline acetate (ester)
Choline acetic acid
Ciba vision brand OF acetylcholine chloride
Cusi, acetilcolina
Fluoride, acetylcholine
Hydroxide, acetylcholine
Iodide, acetylcholine
Iolab brand OF acetylcholine chloride
L-Tartrate, acetylcholine
Miochol
O-Acetylcholine
Perchlorate, acetylcholine
|
|
2 |
|
Cholinergic Agents |
|
Phase 2, Phase 3 |
|
|
|
3 |
|
Neurotransmitter Agents |
|
Phase 2, Phase 3 |
|
|
|
4 |
|
Botulinum Toxins |
|
Phase 2, Phase 3 |
|
|
|
5 |
|
chenodeoxycholic acid |
Approved |
Phase 2 |
|
474-25-9 |
10133 |
Synonyms:
(+)-Chenodeoxycholate
(+)-Chenodeoxycholic acid
(3a,5b,7a)-3,7-Dihydroxy-cholan-24-Oate
(3a,5b,7a)-3,7-Dihydroxy-cholan-24-Oic acid
3a,7a-Dihydroxy-5b,14a,17b-cholanate
3a,7a-Dihydroxy-5b,14a,17b-cholanic acid
3a,7a-Dihydroxy-5b-cholan-24-Oate
3a,7a-Dihydroxy-5b-cholan-24-Oic acid
3a,7a-Dihydroxy-5b-cholanate
3a,7a-Dihydroxy-5b-cholanic acid
3alpha,7alpha-Dihydroxy-5beta-cholanate
3alpha,7alpha-Dihydroxy-5beta-cholanic acid
3α,7α-dihydroxy-5β-cholanate
3α,7α-dihydroxy-5β-cholanic acid
7a-Hydroxy-desoxycholsaeure
7a-Hydroxylithocholate
7a-Hydroxylithocholic acid
7alpha-Hydroxylithocholate
7alpha-Hydroxylithocholic acid
7α-hydroxylithocholate
7α-hydroxylithocholic acid
Acid, chenic
Acid, chenique
Acid, chenodeoxycholic
Acid, gallodesoxycholic
Acide chenodeoxycholique
Acido chenodeoxicholico
Acidum chenodeoxycholicum
Anthropodeoxycholate
|
Anthropodeoxycholic acid
Anthropodesoxycholate
Anthropodesoxycholic acid
Antigen brand OF chenodeoxycholic acid
CDCA
Chenate
Chenic acid
Chenique acid
Chenix
Chenocholic acid
Chenodeoxycholate
Chenodeoxycholate, sodium
Chenodeoxycholic acid
Chenodesoxycholic acid
Chenodesoxycholsaeure
Chenodiol
Chenofalk
Chenophalk
Estedi brand OF chenodeoxycholic acid
Falk brand OF chenodeoxycholic acid
Gallodesoxycholate
Gallodesoxycholic acid
Henohol
Quenobilan
Quenocol
Sodium chenodeoxycholate
Solvay brand OF chenodeoxycholic acid
tramedico Brand OF chenodeoxycholic acid
Zambon brand OF chenodeoxycholic acid
|
|
6 |
|
Atorvastatin |
Approved |
Phase 2 |
|
134523-00-5 |
60823 |
Synonyms:
(3R,5R)-7-[2-(4-fluorophenyl)-3-phenyl-4-(phenylcarbamoyl)-5-propan-2-ylpyrrol-1-yl]-3,5-dihydroxyheptanoic acid
(3R,5R)-7-[3-(anilinocarbonyl)-5-(4-fluorophenyl)-2-isopropyl-4-phenyl-1H-pyrrol-1-yl]-3,5-dihydroxyheptanoic acid
(betaR,deltaR)-2-(p-Fluorophenyl)-beta,delta-dihydroxy-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)pyrrole-1-heptanoic acid
(R-(R*,r*))-2-(4-fluorophenyl)-b,delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-((phenylamino)carbonyl)-1H-pyrrole-1-heptanoate
(R-(R*,r*))-2-(4-fluorophenyl)-b,delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-((phenylamino)carbonyl)-1H-pyrrole-1-heptanoic acid
(R-(R*,r*))-2-(4-fluorophenyl)-b,δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-((phenylamino)carbonyl)-1H-pyrrole-1-heptanoate
(R-(R*,r*))-2-(4-fluorophenyl)-b,δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-((phenylamino)carbonyl)-1H-pyrrole-1-heptanoic acid
(R-(R*,r*))-2-(4-fluorophenyl)-beta,delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-((phenylamino)carbonyl)-1H-pyrrole-1-heptanoate
(R-(R*,r*))-2-(4-fluorophenyl)-beta,delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-((phenylamino)carbonyl)-1H-pyrrole-1-heptanoic acid
(R-(R*,R*))-2-(4-Fluorophenyl)-beta,delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-((phenylamino)carbonyl)-1H-pyrrole-1-heptanoic acid
(R-(R*,r*))-2-(4-fluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-((phenylamino)carbonyl)-1H-pyrrole-1-heptanoate
(R-(R*,r*))-2-(4-fluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-((phenylamino)carbonyl)-1H-pyrrole-1-heptanoic acid
134523-00-5
134523-03-8
7-[2-(4-FLUORO-PHENYL)-5-ISOPROPYL-3-PHENYL-4-PHENYLCARBAMOYL-PYRROL-1-YL]- 3,5-DIHYDROXY-HEPTANOIC ACID
7-[2-(4-fluoro-PHENYL)-5-isopropyl-3-phenyl-4-phenylcarbamoyl-pyrrol-1-yl]-3,5-dihydroxy-heptanoate
7-[2-(4-fluoro-PHENYL)-5-isopropyl-3-phenyl-4-phenylcarbamoyl-pyrrol-1-yl]-3,5-dihydroxy-heptanoIC ACID
AC-15611
AC1L1TZT
AC1Q1OZQ
AKOS000281127
Anhydrous, atorvastatin calcium
Atogal
Atorlip
Atorpic
atorvastatin
Atorvastatin
Atorvastatin (INN)
Atorvastatin [INN:BAN]
Atorvastatin acid
Atorvastatin calcium
Atorvastatin calcium anhydrous
Atorvastatin calcium hydrate
Atorvastatin calcium trihydrate
Atorvastatin, calcium salt
atorvastatina
Atorvastatina
atorvastatine
Atorvastatine
atorvastatinium
atorvastatinum
Atorvastatinum
atrovastin
BIDD:GT0336
C06834
C33H35FN2O5
|
Calcium anhydrous, atorvastatin
Calcium hydrate, atorvastatin
Calcium salt atorvastatin
Calcium trihydrate, atorvastatin
Calcium, atorvastatin
Cardyl
CCRIS 7159
CHEBI:39548
CHEMBL1487
CI 981
CID60823
D07474
DB01076
Faboxim
Hipolixan
HSDB 7039
Hydrate, atorvastatin calcium
Lipitor
Lipitor (TN)
Lipitor(TM)
Lipotropic
Lipovastatinklonal
Liprimar
Liptonorm
Lowden
LS-136975
MolPort-000-883-773
NCGC00159458-02
nchembio.301-comp8
Normalip
Sincol
Sortis
Sortis (TN)
Sotis
Torvacard
Torvast
Totalip
Tozalip
Trihydrate, atorvastatin calcium
Tulip
UNII-A0JWA85V8F
Vastina
Xanator
Xarator
Xavator
Zurinel
|
|
7 |
|
Evolocumab |
Approved |
Phase 1, Phase 2 |
|
1256937-27-5 |
|
Synonyms:
|
8 |
|
Resveratrol |
Investigational |
Phase 2 |
|
501-36-0 |
445154 |
Synonyms:
(e)-5-(2-(4-Hydroxyphenyl)ethenyl)-1,3-benzenediol
(E)-5-(2-(4-hydroxyphenyl)ethenyl)-1,3-benzenediol(E)-5-(2-(4-hydroxyphenyl)ethenyl)-1,3-benzenediol
(e)-Resveratrol
(E)-resveratrol
3,4',5-Stilbenetriol
3,4',5-trihydroxystilbene
3,4',5-Trihydroxystilbene
3,4',5-trihydroxy-trans-stilbene
3,4',5-Trihydroxy-trans-stilbene
3,5,4'-trihydroxystilbene
|
3,5,4'-Trihydroxystilbene
5-[(e)-2-(4-Hydroxyphenyl)vinyl]benzene-1,3-diol
5-[(E)-2-(4-hydroxyphenyl)vinyl]benzene-1,3-diol
cis-Resveratrol
Resveratrol-3-sulfate
SRT 501
SRT-501
trans-3,4',5 - Trihydroxystilbene
trans-resveratrol
trans-Resveratrol
|
|
9 |
|
Gastrointestinal Agents |
|
Phase 2 |
|
|
|
10 |
|
Cathartics |
|
Phase 2 |
|
|
|
11 |
|
Antioxidants |
|
Phase 2 |
|
|
|
12 |
|
Platelet Aggregation Inhibitors |
|
Phase 2 |
|
|
|
13 |
|
Analgesics |
|
Phase 2 |
|
|
|
14 |
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors |
|
Phase 2 |
|
|
|
15 |
|
Analgesics, Non-Narcotic |
|
Phase 2 |
|
|
|
16 |
|
Laxatives |
|
Phase 2 |
|
|
|
17 |
|
Antirheumatic Agents |
|
Phase 2 |
|
|
|
18 |
|
Anti-Inflammatory Agents |
|
Phase 2 |
|
|
|
19 |
|
Protective Agents |
|
Phase 2 |
|
|
|
20 |
|
Anti-Inflammatory Agents, Non-Steroidal |
|
Phase 2 |
|
|
|
21 |
|
Hypolipidemic Agents |
|
Phase 1, Phase 2 |
|
|
|
22 |
|
Lipid Regulating Agents |
|
Phase 1, Phase 2 |
|
|
|
23 |
|
Anticholesteremic Agents |
|
Phase 1, Phase 2 |
|
|
|
24 |
|
Antimetabolites |
|
Phase 1, Phase 2 |
|
|
|
25 |
|
Doxorubicin |
Approved, Investigational |
|
|
23214-92-8 |
31703 |
Synonyms:
(1S,3S)-3-Glycoloyl-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-a-L-lyxo-hexopyranoside
(1S,3S)-3-Glycoloyl-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranoside
(1S,3S)-3-glycoloyl-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-α-L-lyxo-hexopyranoside
(1S,3S)-3-Glycoloyl-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-α-L-lyxo-hexopyranoside
(8S-cis)-10-((3-amino-2,3,6-Trideoxy-a-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-5,12-naphthacenedione
(8S-cis)-10-((3-amino-2,3,6-Trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-5,12-naphthacenedione
(8S-cis)-10-((3-amino-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-5,12-naphthacenedione
(8S-cis)-10-((3-amino-2,3,6-Trideoxy-α-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-5,12-naphthacenedione
111266-55-8
14-hydroxydaunomycin
14-Hydroxydaunomycin
14-hydroxydaunorubicine
14-Hydroxydaunorubicine
23214-92-8
23257-17-2
24385-08-8
25311-50-6
25316-40-9
25316-40-9 (hydrochloride)
29042-30-6
AC1L1M5T
AC1Q29OJ
adiblastine (hydrochloride salt)
ADM
ADR
adr iablatina (hydrochloride salt)
Adriablastin
Adriablastine
adriablastine (hydrochloride salt)
adriablatina (hydrochloride salt)
Adriacin (hydrochloride salt)
Adriamycin
Adriamycin PFS
Adriamycin PFS (hydrochloride salt)
Adriamycin RDF
Adriamycin RDF (hydrochloride salt)
Adriamycin semiquinone
Adriamycin Semiquinone
Adriblas tina
Adriblastin
Adriblastina
Adriblastina (hydrochloride salt)
Adriblastina (TN)
Adriblastine
adriblatina (hydrochloride salt)
Adrimedac
Aerosolized Doxorubicin
Baxter brand OF doxorubicin hydrochloride
Bedford brand OF doxorubicin hydrochloride
BPBio1_000502
BRD-K92093830-003-04-3
Bristol-myers squibb brand OF doxorubicin hydrochloride
BSPBio_000456
BSPBio_001031
C01661
C27H29NO11
Caelyx
CCRIS 739
Cell pharm brand OF doxorubicin hydrochloride
CHEBI:28748
CHEMBL179
CID31703
Columbia brand OF doxorubicin hydrochloride
Conjugate of doxorubicin with humanized monoclonal antibody LL1 against CD74
Conjugate of doxorubicin with monoclonal antibody P4/D10 against GP120
D03899
DB00997
DM2
Doxil
Doxo
doxo Cell
doxo-Cell
Doxolem
doxorubicin
Doxorubicin
Doxorubicin (USAN/INN)
Doxorubicin [USAN:INN:BAN]
Doxorubicin citrate
|
Doxorubicin HCl
Doxorubicin hexal
Doxorubicin hydrochloride
Doxorubicin Hydrochloride
Doxorubicin hydrochloride (hydrochloride salt)
Doxorubicin NC
Doxorubicina
Doxorubicina [INN-Spanish]
Doxorubicina ferrer farm
Doxorubicina funk
Doxorubicina tedec
Doxorubicine
Doxorubicine [INN-French]
Doxorubicine baxter
Doxorubicin-hLL1
Doxorubicin-hLL1 conjugate
Doxorubicin-P4/D10
Doxorubicin-P4/D10 conjugate
Doxorubicinum
Doxorubicinum [INN-Latin]
Doxotec
DOX-SL
EINECS 245-495-6
Elan brand OF doxorubicin hydrochloride
Farmablastina (hydrochloride salt)
Farmiblastina
Ferrer brand OF doxorubicin hydrochloride
FI 106
Hexal brand OF doxorubicin hydrochloride
HMS2089H06
HSDB 3070
Hydrochloride, doxorubicin
Hydroxydaunomycin hydrochlor ide (hydrochloride salt)
Hydroxydaunomycin hydrochloride (hydrochloride salt)
Hydroxydaunorubicin
Hydroxydaunorubicin hydrochloride (hydrochloride salt)
JT9100000
Kenfarma brand OF doxorubicin hydrochloride
Lemery brand OF doxorubicin hydrochloride
LMPK13050001
LS-1029
LS-165655
Medac brand OF doxorubicin hydrochloride
MLS000759533
Myocet
NChemBio.2007.10-comp13
nchembio809-comp5
NCI-C01514
NDC 38242-874
Neocorp brand OF doxorubicin hydrochloride
NIOSH/JT9100000
NSC 123127
Onkodox
Onkoworks brand OF doxorubicin hydrochloride
Pfizer brand OF doxorubicin hydrochloride
Prasfarma brand OF doxorubicin hydrochloride
Prestwick0_000438
Prestwick1_000438
Prestwick2_000438
Prestwick3_000438
Probes1_000151
Probes2_000129
RDF Rubex
Resmycin
Ribodoxo
Ribosepharm brand OF doxorubicin hydrochloride
Rubex
Rubex (hydrochloride salt)
SMP1_000106
SPBio_002395
Tedec meiji brand OF doxorubicin hydrochloride
ThermoDox
TLC D-99
Triferric doxorubicin
UNII-80168379AG
Urokit doxo cell
Urokit doxo-cell
|
|
26 |
|
Idebenone |
Approved, Investigational |
|
|
58186-27-9 |
|
Synonyms:
2-(10-hydroxydecyl)-5,6-dimethoxy-3-methyl-1,4-benzoquinone
2-(10-hydroxydecyl)-5,6-dimethoxy-3-methylcyclohexa-2,5-diene-1,4-dione
2-(10-hydroxydecyl)-5,6-dimethoxy-3-methyl-p-benzoquinone
2,3-dimethoxy-5-methyl-6-(10'-hydroxydecyl)-1,4-benzoquinone
6-(10-hydroxydecyl)-2,3-dimethoxy-5-methyl-1,4-benzoquinone
|
6-(10-hydroxydecyl)-2,3-dimethoxy-5-methyl-p-benzoquinone
idebenona
Idebenone
idébénone
|
|
27 |
|
Choline |
Approved, Nutraceutical |
|
|
62-49-7 |
305 |
Synonyms:
(2-Hydroxyethyl)trimethyl ammonium
(2-Hydroxyethyl)trimethylammonium
(beta-Hydroxyethyl)trimethylammonium
2-Hydroxy-N,N,N-trimethylethanaminium
2-Hydroxy-N,N,N-trimethyl-ethanaminium
Bilineurine
Biocolina
Biocoline
Bitartrate, choline
Bursine
Chloride, choline
Choline bitartrate
Choline cation
Choline chloride
Choline citrate
Choline hydroxide
Choline ion
CHOLINE ion
Choline O sulfate
Choline O-sulfate
|
Cholinum
Citrate, choline
Fagine
Hepacholine
Hormocline
Hydroxide, choline
Lipotril
N,N,N-trimethylethanol-ammonium
N,N,N-Trimethylethanolammonium
N,N,N-Trimethylethanol-ammonium
Neocolina
N-trimethylethanolamine
N-Trimethylethanolamine
O-Sulfate, choline
Paresan
trimethylethanolamine
Trimethylethanolamine
Vidine
Vitamin J
|
|
28 |
|
Creatine |
Approved, Investigational, Nutraceutical |
|
|
57-00-1 |
586 |
Synonyms:
((amino(imino)Methyl)(methyl)amino)acetate
((amino(imino)Methyl)(methyl)amino)acetic acid
((amino(Imino)methyl)(methyl)amino)acetic acid
(alpha-methylguanido)Acetate
(alpha-methylguanido)Acetic acid
(alpha-Methylguanido)acetic acid
(a-methylguanido)Acetate
(a-methylguanido)Acetic acid
(N-methylcarbamimidamido)Acetate
(N-methylcarbamimidamido)acetic acid
(N-methylcarbamimidamido)Acetic acid
(α-methylguanido)acetate
(α-methylguanido)acetic acid
[[amino(imino)Methyl](methyl)amino]acetate
[[amino(imino)Methyl](methyl)amino]acetic acid
alpha-methylguanidino Acetate
alpha-methylguanidino Acetic acid
alpha-Methylguanidino acetic acid
a-methylguanidino Acetate
a-methylguanidino Acetic acid
Cosmocair C 100
Creatin
Creatine
|
Creatine (8CI)
Creatine hydrate
Creatine, hydrate
Kreatin
Krebiozon
Methylglycocyamine
Methylguanidoacetate
Methylguanidoacetic acid
N-(aminoiminomethyl)-N-methylglycine
N-(Aminoiminomethyl)-N-methylglycine
N-(Aminoiminomethyl)-N-methyl-glycine
N-[(e)-amino(imino)METHYL]-N-methylglycine
N-amidinosarcosine
N-Amidinosarcosine
N-carbamimidoyl-N-methylglycine
N-Carbamimidoyl-N-methylglycine
N-methyl-N-guanylglycine
N-Methyl-N-guanylglycine
Phosphagen
Pyrolysate
α-methylguanidino acetate
α-methylguanidino acetic acid
|
|
29 |
|
Aspartic acid |
Approved, Nutraceutical |
|
|
56-84-8 |
5960 |
Synonyms:
(+)-Aspartate
(+)-Aspartic acid
(+-)-Aspartic acid
(2S)-Aspartate
(2S)-Aspartic acid
(L)-Aspartate
(L)-Aspartic acid
(R)-2-Aminosuccinate
(R,S)-Aspartic acid
(S)-(+)-Aspartate
(S)-(+)-Aspartic acid
(S)-2-Aminobutanedioate
(S)-2-aminobutanedioic acid
(S)-2-Aminobutanedioic acid
(S)-2-Aminosuccinate
(S)-2-aminosuccinic acid
(S)-2-Aminosuccinic acid
(S)-amino-Butanedioate
(S)-Aminobutanedioate
(S)-amino-Butanedioic acid
(S)-Aminobutanedioic acid
(S)-Aspartate
(S)-Aspartic acid
2-amino-3-Methylsuccinate
2-amino-3-Methylsuccinic acid
2-Aminosuccinate
2-Aminosuccinic acid
ácido aspártico
Acidum asparticum
alpha-Aminosuccinate
alpha-Aminosuccinic acid
Aminosuccinate
Ammonium aspartate
Asp
Asparagate
Asparagic acid
Asparaginate
Asparaginic acid
Asparatate
ASPARTate
Aspartate magnesium hydrochloride
Aspartate, ammonium
Aspartate, calcium
Aspartate, dipotassium
Aspartate, disodium
Aspartate, magnesium
Aspartate, monopotassium
Aspartate, monosodium
Aspartate, potassium
Aspartate, sodium
|
Aspartic acid
ASPARTIC ACID
Aspartic acid, ammonium salt
Aspartic acid, calcium salt
Aspartic acid, dipotassium salt
Aspartic acid, disodium salt
Aspartic acid, hydrobromide
Aspartic acid, hydrochloride
Aspartic acid, magnesium (1:1) salt, hydrochloride, trihydrate
Aspartic acid, magnesium (2:1) salt
Aspartic acid, magnesium-potassium (2:1:2) salt
Aspartic acid, monopotassium salt
Aspartic acid, monosodium salt
Aspartic acid, potassium salt
Aspartic acid, sodium salt
Calcium aspartate
D
Dipotassium aspartate
Disodium aspartate
H-Asp-OH
Hydrobromide aspartic acid
Hydrochloride aspartic acid
Hydrochloride, aspartate magnesium
L Aspartate
L Aspartic acid
L-(+)-Aspartate
L-(+)-Aspartic acid
L-Aminosuccinate
L-Aminosuccinic acid
L-Asp
L-Asparagate
L-Asparagic acid
L-Asparaginate
L-Asparaginic acid
L-Asparaginsaeure
L-Asparaginsäure
L-Aspartate
L-Aspartic acid
Magnesiocard
Magnesium aspartate
MG 5 Longoral
MG5Longoral
MG-5-Longoral
Monopotassium aspartate
Monosodium aspartate
Poly-DL-succinimide
Polysuccinimide
Potassium aspartate
Sodium aspartate
|
|
30 |
|
N-Methylaspartate |
|
|
|
|
|
31 |
|
Liposomal doxorubicin |
|
|
|
|
31703 |
Synonyms:
|
LipoDox
liposomal doxorubicin
Pegylated Liposomal Doxorubicin Hydrochloride
|
|
Interventional clinical trials:
(show all 18)
# |
Name |
Status |
NCT ID |
Phase |
Drugs |
1 |
Botulinum Toxin in Patients With Hereditary Spastic Paraplegia: a Randomized, Double-blind, Placebo-controlled, Crossover Study |
Completed |
NCT02604186 |
Phase 2, Phase 3 |
|
2 |
Therapeutic Metabolic Intervention in Patients With Spastic Paraplegia SPG5 |
Completed |
NCT02314208 |
Phase 2 |
Xenbilox;Tahor |
3 |
Design and Validation of a Modular Physiotherapy Concept for the Treatment of Hereditary Spastic Spinal Paralysis (HSP) - a Randomized Study |
Completed |
NCT03961906 |
Phase 2 |
|
4 |
PCSK9 Inhibitor Treatment for Patients With Hereditary Spastic Paraplegia Type 5 |
Recruiting |
NCT04101643 |
Phase 1, Phase 2 |
evolocumab |
5 |
A Pilot Study of Repetitive Transcranial Magnetic Stimulation for Improvement of Gait in Hereditary Spastic Paraplegia and Adrenomyeloneuropathy |
Completed |
NCT03627416 |
|
|
6 |
Nuclear Magnetic Spectroscopy for the Evaluation of Primary Lateral Sclerosis, Hereditary Spastic Paraplegia and Amyotrophic Lateral Sclerosis |
Completed |
NCT00023075 |
|
|
7 |
A Patient Centric Motor Neuron Disease Activities of Daily Living Scale |
Completed |
NCT02852278 |
|
|
8 |
Studying Cognition in SPG4 Compared to Healthy Controls |
Completed |
NCT03104088 |
|
|
9 |
The Ability of Strain Echocardiography to Predict Cardiotoxicity in Patients Receiving Standard Chemotherapy Regimens Containing Doxorubicin |
Completed |
NCT02423356 |
|
|
10 |
Disease Natural History and Biomarkers of SPG3A, SPG4 and SPG31 |
Recruiting |
NCT02859428 |
|
|
11 |
Phenotypes, Biomarkers and Pathophysiology in Hereditary Spastic Paraplegias and Related Disorders |
Recruiting |
NCT03981276 |
|
|
12 |
Studying the Presymptomatic and Early Phase of SPG4 |
Recruiting |
NCT03206190 |
|
|
13 |
Phenotype, Genotype & Biomarkers in ALS and Related Disorders |
Recruiting |
NCT02327845 |
|
|
14 |
Improving Gait Adaptability in Hereditary Spastic Paraplegia During Task-specific Training on the C-Mill: Towards Evidence-Based and Individually Tailored Rehabilitation |
Recruiting |
NCT04180098 |
|
|
15 |
Studying Non-motor Symptoms in Patients With Hereditary Spastic Paraplegia (HSP) Compared to Healthy Controls |
Recruiting |
NCT03204773 |
|
|
16 |
SNAP: Measurement of the Subjective Perception of the Symptom in Hereditary Spastic Paraparesis (HSP) |
Recruiting |
NCT04256681 |
|
|
17 |
Clinical and Molecular Manifestations of Neuromuscular and Neurogenetic Disorders of Childhood |
Recruiting |
NCT01568658 |
|
|
18 |
Investigating the Role of SPG20,STK31 Genes in the Carcinogenesis of Colorectal Cancer |
Not yet recruiting |
NCT03261752 |
|
|
|